LEADER 01433oam  2200445   450 
001 9910707259603321
005 20160613083135.0
035   $a(CKB)5470000002462911
035   $a(OCoLC)951607189
035   $a(OCoLC)995470000002462911
035   $a(EXLCZ)995470000002462911
100   $a20160613d2014      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aCompounded drugs under Medicare Part B $epayment and oversight
210  1$a[Washington, D.C.] :$cDepartment of Health and Human Services, Office of Inspector General,$d2014.
215   $a1 online resource (13 pages)
300   $aTitle from title screen (viewed June 1, 2016).
300   $a"April 2014."
300   $a"OEI-03-13-00270."
320   $aIncludes bibliographical references.
517   $aCompounded drugs under Medicare Part B 
606   $aMedicare
606   $aDrugs$xDosage forms$zUnited States$xFinance
606   $aDrugs$xSterilization$zUnited States
606   $aPharmaceutical policy$zUnited States
615  0$aMedicare.
615  0$aDrugs$xDosage forms$xFinance.
615  0$aDrugs$xSterilization
615  0$aPharmaceutical policy
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910707259603321
996   $aCompounded drugs under Medicare Part B$93542614
997   $aUNINA